| Title |
Salvia (Sage): A Review of its Potential Cognitive-Enhancing and Protective Effects
|
|---|---|
| Published in |
Drugs in R&D, November 2016
|
| DOI | 10.1007/s40268-016-0157-5 |
| Pubmed ID | |
| Authors |
Adrian L. Lopresti |
| Abstract |
Genus Salvia, commonly known as sage, is the largest genus in the Lamiaceae family. It comprises many species traditionally used as brain-enhancing tonics. In vitro and animal studies have confirmed that several Salvia species contain a large array of active compounds that may enhance cognitive activity and protect against neurodegenerative disease. In this review, the active constituents in plants belonging to the genus Salvia are summarised, and their influence on pharmacodynamics pertinent to cognitive activity are detailed. In particular, the effects of plants belonging to the genus Salvia and their constituents on cognitive skills including memory, attention and learning are detailed. Their potential effects in dementia, including Alzheimer's disease, are also examined. Completed human trials are summarised, and factors influencing the potency of Salvia plants are covered. Finally, directions for future research are proposed to enhance our understanding of the potential health benefits of Salvia plants. |
X Demographics
The data shown below were collected from the profiles of 24 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 17% |
| United Kingdom | 3 | 13% |
| Germany | 1 | 4% |
| Spain | 1 | 4% |
| Unknown | 15 | 63% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 19 | 79% |
| Scientists | 3 | 13% |
| Practitioners (doctors, other healthcare professionals) | 1 | 4% |
| Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 330 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 330 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 54 | 16% |
| Student > Master | 42 | 13% |
| Student > Ph. D. Student | 28 | 8% |
| Other | 19 | 6% |
| Researcher | 19 | 6% |
| Other | 49 | 15% |
| Unknown | 119 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 39 | 12% |
| Medicine and Dentistry | 27 | 8% |
| Biochemistry, Genetics and Molecular Biology | 26 | 8% |
| Agricultural and Biological Sciences | 26 | 8% |
| Nursing and Health Professions | 15 | 5% |
| Other | 54 | 16% |
| Unknown | 143 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 162. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 April 2024.
All research outputs
#256,676
of 25,755,403 outputs
Outputs from Drugs in R&D
#6
of 374 outputs
Outputs of similar age
#5,161
of 418,538 outputs
Outputs of similar age from Drugs in R&D
#3
of 10 outputs
Altmetric has tracked 25,755,403 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 374 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 418,538 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.